Press Release

Press Release

More
March 2022

Berko Pharmaceuticals Continues Digitalisation in Business Processes

Moving its quality management processes from manual to digital, Berko Pharmaceuticals continues to grow in synchronisation with modern business life. Berko Pharmaceuticals, which has completely digitalised its quality management processes, once again emphasises its innovative and uncompromising quality values by switching to Qmex software validated according to 21 CFR Part 11 requirements.

Berko Pharmaceuticals, which has been working and producing for public health with the motto "For Healthy Tomorrows" for more than thirty-five years, has made an innovation in its quality management processes. Berko Pharmaceuticals, which has completely digitalised its quality management processes, has once again demonstrated its innovative and uncompromising vision of quality with the Qmex software validated according to 21 CFR Part 11 requirements, where all information of its employees can be easily accessed.

With Qmex, it is aimed to provide many benefits such as electronic signature, module-based authorisation, audit trail, record history, action-based scheduled notifications, personal page, pending jobs, delegated jobs, bookmarks, graphics and reporting, tracking trend reports, adding multiple files, related records screen, integration between modules, integration with all 3rd party software including ERPs, strong workflow management, company reputation.

Berko Pharmaceuticals will be able to easily access all information on a single platform by switching to the Qmex software system. Quality Assurance Manager Dr. Chem. Haluk Akkuş said; "We crowned our innovative and forward-looking vision by switching our business processes to Qmex. We are happy to be a part of the digital age in the business management processes we use in the company."